ATE211825T1 - Verfahren zur feststellung einer allergie - Google Patents

Verfahren zur feststellung einer allergie

Info

Publication number
ATE211825T1
ATE211825T1 AT96910050T AT96910050T ATE211825T1 AT E211825 T1 ATE211825 T1 AT E211825T1 AT 96910050 T AT96910050 T AT 96910050T AT 96910050 T AT96910050 T AT 96910050T AT E211825 T1 ATE211825 T1 AT E211825T1
Authority
AT
Austria
Prior art keywords
allergy
pct
probability
date
sec
Prior art date
Application number
AT96910050T
Other languages
English (en)
Inventor
Esa-Matti Lilius
Erika Isolauri
Seppo Salminen
Original Assignee
Aboatech Ab Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aboatech Ab Oy filed Critical Aboatech Ab Oy
Application granted granted Critical
Publication of ATE211825T1 publication Critical patent/ATE211825T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/805—Drug, bio-affecting and body treating compositions involving IgE or IgD
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
AT96910050T 1995-04-12 1996-04-12 Verfahren zur feststellung einer allergie ATE211825T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI951778A FI951778A7 (fi) 1995-04-12 1995-04-12 Menetelmä allergian toteamiseksi
PCT/FI1996/000199 WO1996032645A1 (en) 1995-04-12 1996-04-12 Method for detecting allergy

Publications (1)

Publication Number Publication Date
ATE211825T1 true ATE211825T1 (de) 2002-01-15

Family

ID=8543239

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96910050T ATE211825T1 (de) 1995-04-12 1996-04-12 Verfahren zur feststellung einer allergie

Country Status (8)

Country Link
US (1) US5858690A (de)
EP (1) EP0820594B1 (de)
AT (1) ATE211825T1 (de)
AU (1) AU708909B2 (de)
CA (1) CA2217898A1 (de)
DE (1) DE69618451T2 (de)
FI (1) FI951778A7 (de)
WO (1) WO1996032645A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6498247B2 (en) * 2000-04-13 2002-12-24 Pro-Health, Inc. Alkali or alkaline earth metal of n-butyric acid for treatment of cognitive and emotional conditions
US20030022250A1 (en) * 2001-05-29 2003-01-30 Dreskin Stephen C. Functional IgE test methods and compositions
FI115165B (fi) 2001-06-04 2005-03-15 Aboatech Ab Oy Menetelmä infektion laadun määrittämiseksi
RU2289816C1 (ru) * 2005-07-06 2006-12-20 Государственное образовательное учреждение высшего профессионального образования Санкт-Петербургская государственная педиатрическая медицинская академия Федерального агентства по здравоохранению и социальному развитию Способ определения функциональной активности фагоцитов
CN104677810B (zh) * 2015-01-30 2017-08-22 广东医学院附属医院 嗜碱性粒细胞活化的检测试剂盒及其使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693967A (en) * 1981-02-18 1987-09-15 Research Corporation Monitoring therapy results in body samples of receptor cells
US5192665A (en) * 1985-11-22 1993-03-09 Labsystems, Oy Method of ophthalmic testing
US4954617A (en) * 1986-07-07 1990-09-04 Trustees Of Dartmouth College Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes
US5409901A (en) * 1987-07-02 1995-04-25 Calabrese; Alberto I. Therapeutic compositions comprising nucleoproteins as the active agents, and methods of producing and using such compositions
US5219997A (en) * 1987-07-06 1993-06-15 Dana-Farber Cancer Institute Monoclonal antibody which inhibits the adhesion functions of the β integrin, CR3
ATE81724T1 (de) * 1987-11-09 1992-11-15 Becton Dickinson Co Verfahren zur analyse haematopoietischer zellen in einer probe.
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US5547669A (en) * 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
CA2097417A1 (en) * 1991-10-01 1993-04-01 Alain Ladislas De Weck Method for the determination of sulfidoleukotrienes in tissues and biological fluids and its application in diagnosis of allergies and other inflammatory diseases

Also Published As

Publication number Publication date
FI951778L (fi) 1996-10-13
WO1996032645A1 (en) 1996-10-17
FI951778A0 (fi) 1995-04-12
DE69618451T2 (de) 2002-09-26
FI951778A7 (fi) 1996-10-13
AU708909B2 (en) 1999-08-12
DE69618451D1 (de) 2002-02-14
CA2217898A1 (en) 1996-10-17
AU5336796A (en) 1996-10-30
EP0820594B1 (de) 2002-01-09
US5858690A (en) 1999-01-12
EP0820594A1 (de) 1998-01-28

Similar Documents

Publication Publication Date Title
ATE246361T1 (de) Verfahren zur bestimmung von ige
DE69836888D1 (de) Verfahren für Fluoreszenzerkennungstest
DE69025199D1 (de) Verfahren zum in vivo-nachweis von knochenresorption
ATE98773T1 (de) Verfahren zur optischen analyse.
DE68918103D1 (de) Verfahren zur überwachung des kollagenabbaus.
ATE234466T1 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
DE69105978D1 (de) Verfahren zur verminderung von störungen in einer fluoreszenzbestimmung.
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
DE69618451D1 (de) Verfahren zur feststellung einer allergie
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
DE69214843D1 (de) Verfahren zum nachweis von beschädigungen des magenepithels
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
NO973823L (no) Påvisning av antistoffproduksjon
DE69623276D1 (de) Verfahren zur diagnose von chlamydia in einer biologischen extrazellulären flüssigkeit
DE69431051D1 (de) Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
EP0774970A4 (de) Verfahren zur verwendung von hyaluronsäure zur detektion, lokalisation und diagnose von tumoren
ES2099876T3 (es) Procedimiento para la determinacion de anticuerpos de lupus anticoagulante que provocan trombosis.
ATE212066T1 (de) Verwendung einer genveränderung im gen für die humane g-protein beta3-untereinheit zur diagnostik von erkrankungen
DE59611194D1 (de) Verfahren und mittel zur bestimmung von jodid
ATE246809T1 (de) Verfahren zur bestimmung der alkoholkonsumrate
ATE237139T1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten
DE69521145D1 (de) Verfahren zur kompetitiven bestimmung eines haptens

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties